ArticleSmall methods2026
Proximity Proteomics Maps Candidate Cellular Uptake Pathways for Cell-Derived Nanovesicles.
Article in Small methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Although extracellular vesicles (EVs) facilitate selective molecular exchange between cells, their low yields and inherent heterogeneity limit translational applications. Cell-derived nanovesicles (CDNs), produced by mechanical extrusion of donor cells, offer a scalable alternative while retaining key membrane features of EVs. Yet how fabrication reshapes vesicle-cell communication remains poorly understood. Here, vesicle-side proteomics is integrated with TurboID proximity labeling of recipient-cell proteins to construct quantitative, dual-sided maps of CDN and small extracellular vesicle (sEV) interactions. Despite similar size and surface charge, CDNs displayed a substantially more diverse proteome and a broader repertoire of predicted uptake-associated signatures. Recipient-cell proximity proteomics further resolved distinct molecular cohorts. The CDN-associated cohort contained recipient-derived CALR and NCL, which are literature-linked to LRP1/CD91-associated efferocytic recognition and NCL-associated macropinocytic processes, respectively, whereas the sEV-associated cohort contained signatures consistent with HSPG-assisted docking and clathrin-mediated or CLIC/GEEC-related uptake. Together, these complementary datasets reveal molecular interfaces for extrusion-generated CDNs that are distinct from those of naturally secreted sEVs. Receptor dependence and the contributions of surface association and internalization require direct testing; however, the identified associations define specific mechanistic targets for further investigation. This dual-sided proteomic strategy establishes a quantitative framework for dissecting vesicle-cell communication and engineering membrane-based nanocarriers.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.